NCT07319468

Brief Summary

o Sixty-nine adult patients from both sexes. They were suffering from ESRD on maintenance hemodialysis, their age ranged from50-60 years old were selected from hemodialysis unit at Itay El Baroud central hospital. They were referred by the physician.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Jan 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Jan 2026Jun 2026

First Submitted

Initial submission to the registry

December 9, 2025

Completed
23 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 6, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

January 6, 2026

Status Verified

December 1, 2025

Enrollment Period

4 months

First QC Date

December 9, 2025

Last Update Submit

December 20, 2025

Conditions

Keywords

Aerobic ExerciseChronic kidney diseaseHemodialysisFunctional Capacity

Outcome Measures

Primary Outcomes (2)

  • Fatigue Questionnaire (Fatigue Severity Scale)

    The Fatigue Severity Scale it used to assess the level of fatigue. The Fatigue Severity Scale scores range from 9 to 36 where higher scores indicate worse fatigue and lower scores indicate improvement in fatigue.

    8 weeks

  • 6-Minutes walk test

    The 6-min walk test (6MWT) is frequently used to measure physical function in transplanted patients

    8 weeks

Secondary Outcomes (3)

  • Laboratory investigation (Urea analysis)

    8 weeks

  • The Mini-Cog test

    8 weeks

  • Laboratory investigation (creatinine analysis)

    8 weeks

Study Arms (3)

Aerobic exercise

EXPERIMENTAL

(23) patients who received aerobic exercise in form of (foot pedal exerciser) for 20 Minutes for each session, 3 sessions per week, for 8 weeks.

Device: Aerobic exercises

Active free range of motion exercise

EXPERIMENTAL

(23) patients who received active free range of motion exercise (open kinetic chain active free range of motion) for 20 minutes for each session, 3 sessions per week, for 8 weeks.

Other: Open kinetic chain active free range of motion

control group

OTHER

(23) patients who will receive standard medical treatment for end-stage renal disease, including regular hemodialysis sessions and pharmacological management (e.g., Epoetin alfa and phosphate binders) as prescribed by their nephrologist, without participating in the physical therapy exercise program.

Other: No intervention

Interventions

Foot pedal exerciser: * Simple horizontal foot pedal exerciser used during hemodialysis sessions. * Dual pedals with non-slip straps for foot stability. * Manual resistance adjustment via a single control knob (non-electric). * Provides gradual increase in workload intensity. * Compact and light weight design suitable for use while lying on the dialysis bed. * Enables controlled, low-impact circular movement of the feet. * Aims to improve circulation and strengthen lower limb muscles without requiring active sitting. * Approximate device dimensions: 50 cm (length) x 40 cm (width) x 23 cm (height). * Maximum recommended user weight: 70 kg.

Aerobic exercise

Participants completed the 30-min aerobic exercise sessions during the first 2 hrs. of each dialysis session, 3 times per week for 8 weeks, using a simulated bike riding. Patients will perform active free exercise for upper limb (the arm that hasn't shunt) and lower limbs. Each exercise session consisted of three phases: warm up, conditioning, and cool down.

Active free range of motion exercise

the control group will receive only the standard medical care provided by dialysis center without any physical therapy intervention

control group

Eligibility Criteria

Age50 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • All patients were included according to the following criteria:
  • Age between 50-60years.
  • The patients had been on hemodialysis for at least 3 months with three sessions per week for 3-4hr per session.
  • The patients were diagnosed with end stage renal failure (stage5 CKD) on maintenance regular HD (three sessions/week (on alternate days), for four hours/session) for more than three months. (Receiving HD through uncomplicated arm arteriovenous (A-V) fistula
  • Under medical control
  • Both men and women were enrolled
  • Body math index ranged from 18,5- 24.9 kg/m²

You may not qualify if:

  • Patients who experienced or had one or more of the following were excluded from the study:
  • Patients with resting systolic blood pressure \>200 mmHg and/or diastolic blood pressure \>120 mmHg.
  • patients with neurological problems (e.g. stroke, head injury)
  • patients with musculoskeletal problems (e.g. sever osteoarthritis or difficulties in ambulation)
  • Patients with uncontrolled pulmonary disease. (e.g. exaggerated chronic obstructive pulmonary disease, acute asthma)
  • Patients with mental health problems and cognitive impairment due to inability to teach them how to make respiratory training.
  • Any patient who missed more than two weeks of the program or want to terminate the program.
  • Severe obesity (BMI \>35)
  • Presence of malignant disease.
  • Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, acute pericarditis or myocarditis.
  • The patients had hearing impairment or mental disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Research Ethical Committee Cairo University

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Faten Mahmoud Eldesouky, Master in Physical Therapy

CONTACT

Research Ethical Committee, Principal Investigator

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant of Physical Therapy, Chest Hospital, Damanhour, Elbeheira

Study Record Dates

First Submitted

December 9, 2025

First Posted

January 6, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

January 6, 2026

Record last verified: 2025-12